Case Study: How to Deploy AI in GxP Environments - (Without Getting Trapped in Validation)
Probabilistic AI breaks traditional validation frameworks, leaving clinical and regulatory teams stuck
The FDA are paying attention - Exer Labs Warning Letter
Avoid the compliance pitfalls that led to the Exer Labs FDA warning letter. Discover how a GxP-AI Management System (AMS) integrates AI governance into your QMS for total lifecycle oversight.
AI meets GxP: Model Cards for Trust, Transparency and Compliance
Artificial intelligence is shaking up the pharmaceutical industry, delivering efficiencies in manufacturing,
Why SaaS Vendors Are Racing to Add GenAI in Life Sciences: An Analysis of MIT’s State of AI in Business 2025
By Ben O'Brien 01/09/2025
Introduction: The Growing Impact
When “Imperfect” AI Models Still Add Value in Pharma Quality
Introduction: Quality mindset in an AI world
Artificial intelligence is rapidly reshaping